Noopept (N-phenylacetyl-L-prolylglycine ethyl ester) protects nerve cells and boosts thinking through several molecular routes. It activates Sig1R (the sigma-1 receptor, a protective sensor in cells), which raises brain growth factors, especially BDNF, through CREB (a protein that switches on genes) and ERK1/2 (a signaling enzyme). Stronger BDNF signaling through TrkB receptors (the docking sites BDNF binds to) helps brain cells survive, grow branches (dendritic arborization), and form new connections (synaptogenesis). Noopept also improves mitochondrial (the power plants inside your cells) function and ATP (cell fuel) production by activating the respiratory chain complexes (the protein machines that make energy) and adjusting uncoupling protein 2, so cells have more energy available. It reduces glutamate excitotoxicity (damage from overactive signaling) by adjusting NMDA and AMPA receptors (two kinds of docking sites for glutamate, an excitatory brain chemical), and it restores depleted glutathione (GSH, a key antioxidant), protecting against oxidative stress (cell damage from unstable oxygen molecules). Noopept lowers the production of inflammatory signals (TNF-α, IL-6, IL-1β) in microglia (the brain's immune cells) by suppressing NF-κB (a master switch for inflammation), which reduces neuroinflammation (inflammation in the brain). The peptide crosses the blood-brain barrier (the filter between blood and brain) both by carrier-mediated transport (protein carriers) and by direct diffusion, thanks to its fat-loving (lipophilic) ester part. It also boosts blood flow to the brain by activating endothelial NO synthase (an enzyme that makes nitric oxide, a gas that relaxes blood vessels) and protects against amyloid-beta toxicity (amyloid-beta is a sticky protein that builds up in Alzheimer's disease) by stopping it from clumping (anti-aggregation).